Literature DB >> 24302757

Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.

Qinglai Meng1, M R Sandhya Rani, Julia M Sugalski, Chelsey J Judge, Sarah Phat, Benigno Rodriguez, Ronald E Blanton, Donald D Anthony.   

Abstract

BACKGROUND: Natural killer (NK) cells are implicated in the pathogenesis of hepatitis C virus (HCV) infection and outcome of interferon (IFN)-α based therapy, although mechanisms remain unclear.
METHODS: To evaluate NK ability to control HCV infection, we analyzed healthy donor and HCV-infected donor NK-cell cytolytic activity directed at HCV-infected target cells.
RESULTS: HCV-infected subjects' natural cytotoxicity receptor (NCR)-dependent NK-cell cytolytic activity directed at HCV-infected and uninfected Huh7.5 target cells was greater than that of cells from healthy donors, and this localized to the African American subset. However, IFN-α-enhanced NK cytolytic function was lower in HCV-infected subjects, again localized mainly to the African American subset. Additionally, whereas HCV-infected Huh7.5 cells were more readily targeted than uninfected cells, the selectivity of cytolytic activity for infected targets was lower during HCV infection and after IFN-α stimulation, and lower selectivity was in part attributable to greater NKp46 expression. Furthermore, cytolytic activity was associated with higher serum aspartate aminotransferase, rs12979860 IL28B genotype, and in vivo response to pegylated IFN/ribavirin therapy.
CONCLUSIONS: These data indicate that during chronic HCV infection, race-associated increase in NCR expression and IL28B-associated cytolytic activity may participate in host response to IFN-α-containing HCV therapy.

Entities:  

Keywords:  hepatitis C; human; infection; liver; natural killer

Mesh:

Substances:

Year:  2013        PMID: 24302757      PMCID: PMC3997579          DOI: 10.1093/infdis/jit677

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

Authors:  Andrea De Maria; Manuela Fogli; Stefania Mazza; Monica Basso; Antonio Picciotto; Paola Costa; Sonia Congia; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

2.  NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Anke Hahn; Janina Geiler; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Biochem Biophys Res Commun       Date:  2005-11-14       Impact factor: 3.575

3.  Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.

Authors:  Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian Willberg; Kwok Tang; Phillipa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.

Authors:  Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

Authors:  Joo Chun Yoon; Masaaki Shiina; Golo Ahlenstiel; Barbara Rehermann
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

6.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

Authors:  Barbara Oliviero; Stefania Varchetta; Enrica Paudice; Giuseppe Michelone; Marco Zaramella; Domenico Mavilio; Francesca De Filippi; Savino Bruno; Mario U Mondelli
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

7.  Natural killer cells suppress full cycle HCV infection of human hepatocytes.

Authors:  S-H Wang; C-X Huang; L Ye; X Wang; L Song; Y-J Wang; H Liang; X-Y Huang; W-Z Ho
Journal:  J Viral Hepat       Date:  2008-07-10       Impact factor: 3.728

8.  Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.

Authors:  L Golden-Mason; L Madrigal-Estebas; E McGrath; M J Conroy; E J Ryan; J E Hegarty; C O'Farrelly; D G Doherty
Journal:  Gut       Date:  2008-03-27       Impact factor: 23.059

9.  Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus.

Authors:  N Paladino; A C Flores; C Y Marcos; H Fainboim; G Theiler; L Arruvito; F Williams; D Middleton; L Fainboim
Journal:  Tissue Antigens       Date:  2007-04

10.  Histone deacetylase inhibitors suppress natural killer cell cytolytic activity.

Authors:  Henry Ogbomo; Martin Michaelis; Jörg Kreuter; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  FEBS Lett       Date:  2007-03-01       Impact factor: 4.124

View more
  6 in total

1.  CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections.

Authors:  Chelsey J Judge; Lenche Kostadinova; Kenneth E Sherman; Adeel A Butt; Yngve Falck-Ytter; Nicholas T Funderburg; Alan L Landay; Michael M Lederman; Scott F Sieg; Johan K Sandberg; Donald D Anthony
Journal:  J Leukoc Biol       Date:  2017-04-11       Impact factor: 4.962

2.  Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.

Authors:  B E Verstrepen; I G Nieuwenhuis; P Mooij; W M Bogers; A Boonstra; G Koopman
Journal:  Clin Exp Immunol       Date:  2016-04-27       Impact factor: 4.330

3.  Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.

Authors:  Rikke Olesen; Selena Vigano; Thomas A Rasmussen; Ole S Søgaard; Zhengyu Ouyang; Maria Buzon; Arman Bashirova; Mary Carrington; Sarah Palmer; Christel R Brinkmann; Xu G Yu; Lars Østergaard; Martin Tolstrup; Mathias Lichterfeld
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

4.  HBD-3 induces NK cell activation, IFN-γ secretion and mDC dependent cytolytic function.

Authors:  Chelsey J Judge; Elane Reyes-Aviles; Sara J Conry; Scott S Sieg; Zhimin Feng; Aaron Weinberg; Donald D Anthony
Journal:  Cell Immunol       Date:  2015-06-30       Impact factor: 4.868

5.  Regulation of Interferon-Stimulated Gene BST2 by a lncRNA Transcribed from a Shared Bidirectional Promoter.

Authors:  Hiroto Kambara; Lalith Gunawardane; Elizabeth Zebrowski; Lenche Kostadinova; Raul Jobava; Dawid Krokowski; Maria Hatzoglou; Donald D Anthony; Saba Valadkhan
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

6.  Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth.

Authors:  Ahmed Lasfar; Andrew de laTorre; Walid Abushahba; Karine A Cohen-Solal; Ismael Castaneda; Yao Yuan; Kenneth Reuhl; Andrew Zloza; Elizabeth Raveche; Debra L Laskin; Sergei V Kotenko
Journal:  Oncotarget       Date:  2016-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.